TY  - CONF

T1  - Abstract 18: Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy

JO  - Clinical Cancer Research

UR  - https://doi.org/10.1158/1557-3265.hemmal17-18

PY  - 2017/12/14

AU  - Müller LME

AU  - Parrish C

AU  - Migneco G

AU  - Scott GB

AU  - Holmes M

AU  - Melcher AA

AU  - Lawson MA

AU  - Cook G

AU  - Errington-Mais F

ED  - 

DO  - DOI: 10.1158/1557-3265.hemmal17-18

PB  - American Association for Cancer Research (AACR)

VL  - 23

IS  - 24_Supplement

SP  - 18

EP  - 18

Y2  - 2025/11/15

ER  -